Par Drugs And Chemicals Limited

Healthcare

NSE: PAR
₹125.79
▲ 1.84 (1.48%)
Oct. 5, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
49/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
40.6
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹14 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 2 met
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.5%
Low 118.0100 · High 126.9500
1W return
-3.3%
Low 118.0100 · High 132.6000
1M return
-19.7%
Low 118.0100 · High 148.8800
52W return
18.1%
Low 78.0500 · High 180.0000
Lifetime High ₹348.4500 (Dec. 2, 2024)
Lifetime Low ₹27.5000 (April 1, 2020)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish3
5D
126.6
10D
128.8
20D
129.1
50D
120.5
100D
110.9
200D
98.9

Delivery and volume

Day avg. delivery
25.0%
Week avg. delivery
22.2%
Month avg. delivery
24.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

123.58
Pivot
First resistance129.16
Second resistance132.52
Third resistance138.10
First support120.22
Second support114.64
Third support111.28
Day RSI48.5
Day MFI39.3
Day MACD1.58
Day MACD signal4.15

Beta

1M1.24
3M1.26
1Y1.09
3Y0.91

Price change analysis

↓ -19.7%
Over 1 Month
LowHigh
118.01148.88
↑ 39.0%
Over 3 Months
LowHigh
87.61180.00
↑ 46.9%
Over 6 Months
LowHigh
81.00180.00
↑ 18.1%
Over 1 Year
LowHigh
78.05180.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹31 Cr
Net profit (June 30, 2026)
₹5 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter73.41%

Largest holders

NameCategoryShares %Shares
Jignesh Vallabhbhai SavaniPromoter21.8800%2692440
Falgun Vallabhbhai SavaniPromoter21.5000%2645952
Saritaben Vallabhbhai SavaniPromoter20.5200%2525318
Ghanshayambhai B SavaniPromoter6.5200%802284
Econo Trading And Investment Private LimitedPublic1.8000%221872

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 73.41% in Jun 2026 qtr

Historical fii holding

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 56 insider trades, 52 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
4 Dec 2025 SARITABEN VALLABHBHAI SAVANI Promoter group Buy 0 ₹0
27 Aug 2024 SARITABEN VALLABHBHAI SAVANI Promoter group Sell 0 ₹0
27 Aug 2024 SARITABEN VALLABHBHAI SAVANI Promoter group Sell 0 ₹0
23 Jun 2022 SARITABEN VALLABHBHAI SAVANI Promoter group Buy 0 ₹0
11 Mar 2022 RITA HARESH RADADIYA Promoter group Buy 0 ₹0
11 Mar 2022 GHANSHAYAMBHAI BHAGVANBHAI SAVANI Promoter group Buy 0 ₹0
9 Mar 2022 NAYNA JIGNESH SAVANI Promoter group Buy 0 ₹0
9 Mar 2022 JIGNESH VALLABHBHAI SAVANI Promoter Buy 0 ₹0
9 Mar 2022 VALLABHBHAI JIVABHAI SAVANI Promoter group Buy 0 ₹0
6 Mar 2022 NAYNA JIGNESH SAVANI Promoter group Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
2 Sep 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 73,318 159.0800 NSE
2 Sep 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 73,318 158.8700 NSE
2 Sep 2026 NIKUNJ SHAH Bulk Sell 62,138 168.5000 NSE
2 Sep 2026 NIKUNJ SHAH Bulk Buy 111,838 167.6200 NSE
23 Mar 2026 INVESTERIA FINANCIAL SERVICES PRIVATE LIMITED Bulk Sell 221,872 85.0000 NSE
23 Mar 2026 ECONO TRADING & INVESTMENT PRIVATE LIMITED Bulk Buy 221,872 85.0000 NSE
20 Mar 2026 INVESTERIA FINANCIAL SERVICES PRIVATE LIMITED Bulk Buy 121,872 89.4500 NSE
20 Mar 2026 ECONO TRADING & INVESTMENT PRIVATE LIMITED Bulk Sell 121,872 89.4500 NSE
19 Mar 2026 INVESTERIA FINANCIAL SERVICES PRIVATE LIMITED Bulk Buy 100,000 88.9500 NSE
19 Mar 2026 ECONO TRADING & INVESTMENT PRIVATE LIMITED Bulk Sell 99,301 88.9500 NSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
22 Nov 2021 Interim Dividend - Rs 1.25 Per Share 1.2500 23 Nov 2021

Corporate Actions

Full history (5 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
23 Dec 2024OTHERExtra Ordinary General Meeting
13 Sep 2024OTHERAnnual General Meeting
8 Sep 2023OTHERAnnual General Meeting
1 Sep 2022OTHERAnnual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
22 Aug 2026 Other business matters —
8 Aug 2026 Financial Results/Other business matters Yes
14 May 2026 Financial Results/Other business matters Yes
10 Feb 2026 Financial Results/Other business matters Yes
13 Nov 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 440 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Trading Window Par Drugs And Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
27 Sep 2026 Shareholders meeting Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2026. Further, the company has informed the Exchange regarding voting results.
26 Sep 2026 Updates Par Drugs And Chemicals Limited has informed the Exchange regarding 'Proceeding of AGM dated 26.09.2026'.
26 Sep 2026 Shareholders meeting Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2026
5 Sep 2026 Copy of Newspaper Publication Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
1 Sep 2026 Updates Par Drugs And Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)'.
22 Aug 2026 Shareholders meeting Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026
22 Aug 2026 Outcome of Board Meeting Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2026.
22 Aug 2026 Appointment Par Drugs And Chemicals Limited has informed the Exchange regarding Appointment of Ms SIDDHPURA & CO, Internal Auditor as Internal auditor of the company w.e.f. April 01, 2026.
22 Aug 2026 Appointment Par Drugs And Chemicals Limited has informed the Exchange regarding Appointment of M/s Maulin Shah & Associates, Cost Accountant as Cost Auditor of the Company w.e.f. April 01, 2026.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Par Drugs And Chemicals Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.